A PYMNTS Company

Germany/China: Pharma tech merger delayed for ongoing review

By  |  February 14, 2014

German pharmaceutical technology firm Merck announced that the anticipated timetable for its acquisition of UK-based AZ Electronic Materials has been extended due to the ongoing merger review by Chinese regulators.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    Reports say the company extended its acquisition offer until the last day of February as China’s Ministry of Commerce continues to review the deal.

    While the deal is delayed, Merck has also announced antitrust clearance for the deal from Japanese regulators. Clearance has already been granted in Germany, Taiwan and the US, say reports.

    Full Content: TWST

    Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.